Table 1

- Comparisons of clinical and demographic parameters of axSpA and control group

CharacteristicsaxSpA, n=44Control, n=29P-value
Age (years)38.65±10.0441.48±11.720.998
Gender, n (%)
Female13 (61.9%)8 (38.1%)0.856
Male31 (59.6%)21 (40.4%)
BMI (kg/m2)25.79±4.1625.89±2.890.911
GDF-15 (ng/L)103.11 (48.40-166.56)86.37 (37.45-157.51)0.543
WBC (103/ µL)8332.27±1468.128113.44±1729.960.564
ESR (mm/h)10 (4.0-18.75)7 (4.0-17.0)0.568
Hemoglobin(g/dL)14.30±1.3614.65±1.360.295
CRP (mg/dL)0.55 (0.14-1.05)0.33 (0.13-0.77)0.245
Platelet count(103/µL)287479.5422±58592269975.86±51697.280.195
EF (%)63.45±2.5263.89±2.710.480
EAT thickness (cm)0.35±0.090.26±0.06<0.001

AxSpA: axial spondyloarthritis, ESR: erythrocyte sedimentation rate, BMI: Body mass index, GDF-15: growth differentiation factor 15, CRP: C-reactive protein; EF: ejection fraction, EAT: epicardial adipose tissue; cm: centimeter, WBC: white blood cell